CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research.
about
CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism.CRISPR/Cas9: at the cutting edge of hepatology.Research on the hepatotoxicity mechanism of citrate-modified silver nanoparticles based on metabolomics and proteomics.
P2860
CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CRISPR knockout rat cytochrome ...... and pharmacokinetics research.
@en
CRISPR knockout rat cytochrome ...... and pharmacokinetics research.
@nl
type
label
CRISPR knockout rat cytochrome ...... and pharmacokinetics research.
@en
CRISPR knockout rat cytochrome ...... and pharmacokinetics research.
@nl
prefLabel
CRISPR knockout rat cytochrome ...... and pharmacokinetics research.
@en
CRISPR knockout rat cytochrome ...... and pharmacokinetics research.
@nl
P2093
P2860
P50
P356
P1433
P1476
CRISPR knockout rat cytochrome ...... and pharmacokinetics research.
@en
P2093
P2860
P2888
P356
10.1038/SREP42922
P407
P577
2017-02-20T00:00:00Z